Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.222 DKK | -2.86% | -3.02% | -41.53% |
Sales 2024 * | 40M 5.71M | Sales 2025 * | - | Capitalization | 464M 66.23M |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.42M | Net income 2025 * | - | EV / Sales 2024 * | 11.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-12.2
x | P/E ratio 2025 * |
-
| Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | -2.86% | ||
1 week | -3.02% | ||
Current month | -6.57% | ||
1 month | -7.98% | ||
3 months | -42.49% | ||
6 months | -22.07% | ||
Current year | -41.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 1.222 | -2.86% | 386,107 |
24-04-19 | 1.258 | +0.32% | 274,377 |
24-04-18 | 1.254 | -1.57% | 127,316 |
24-04-17 | 1.274 | +0.63% | 219,138 |
24-04-16 | 1.266 | +0.48% | 274,696 |
Delayed Quote Nasdaq Copenhagen, April 22, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.53% | 66.19M | |
+0.10% | 12.66B | |
-17.03% | 7.04B | |
+1.73% | 4.32B | |
-2.51% | 4.45B | |
-50.32% | 3.31B | |
+6.90% | 2.6B | |
-16.74% | 2.01B | |
-3.40% | 1.67B | |
-6.24% | 1.45B |
- Stock Market
- Equities
- BIOPOR Stock